Vγ39Vδ2 T cells are activated by phosphoantigens, such as isopentenyl pyrophosphate (IPP), which is generated in the mevalonate pathway of antigen-presenting cells. IPP is released in the extracellular microenvironment via unknown mechanisms. Here we show that the ATP-binding cassette transporter A1 (ABCA1) mediates extracellular IPP release from dendritic cells (DC) in cooperation with apolipoprotein A-I (apoA-I) and butyrophilin-3A1. IPP concentrations in the supernatants are sufficient to induce Vγ39Vδ2 T cell proliferation after DC mevalonate pathway inhibition with zoledronic acid (ZA). ZA treatment increases ABCA1 and apoA-I expression via IPP-dependent LXRα nuclear translocation and PI3K/Akt/mTOR pathway inhibition. These results close the mechanistic gap in our understanding of extracellular IPP release from DC and provide a framework to fine-tune Vγ39Vδ2 T cell activation via mevalonate and PI3K/Akt/mTOR pathway modulation.

The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ39Vδ2 T cell activation by dendritic cells / B. Castella, J. Kopecka, P. Sciancalepore, G. Mandili, M. Foglietta, N. Mitro, D. Caruso, F. Novelli, C. Riganti, M. Massaia. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 8:(2017 Jun 05). [10.1038/ncomms15663]

The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ39Vδ2 T cell activation by dendritic cells

N. Mitro
Membro del Collaboration Group
;
D. Caruso;
2017

Abstract

Vγ39Vδ2 T cells are activated by phosphoantigens, such as isopentenyl pyrophosphate (IPP), which is generated in the mevalonate pathway of antigen-presenting cells. IPP is released in the extracellular microenvironment via unknown mechanisms. Here we show that the ATP-binding cassette transporter A1 (ABCA1) mediates extracellular IPP release from dendritic cells (DC) in cooperation with apolipoprotein A-I (apoA-I) and butyrophilin-3A1. IPP concentrations in the supernatants are sufficient to induce Vγ39Vδ2 T cell proliferation after DC mevalonate pathway inhibition with zoledronic acid (ZA). ZA treatment increases ABCA1 and apoA-I expression via IPP-dependent LXRα nuclear translocation and PI3K/Akt/mTOR pathway inhibition. These results close the mechanistic gap in our understanding of extracellular IPP release from DC and provide a framework to fine-tune Vγ39Vδ2 T cell activation via mevalonate and PI3K/Akt/mTOR pathway modulation.
chemistry (all); biochemistry, genetics and molecular biology (all); physics and astronomy (all)
Settore BIO/10 - Biochimica
5-giu-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
ncomms15663.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.4 MB
Formato Adobe PDF
1.4 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/549825
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 51
social impact